Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00308932 · ClinicalTrials.gov registry record · Phase 4

Effect of Age and Device on Delivery of Fluticasone

A Phase 4 study, sponsored by University of Florida.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target

NCT00308932: Completed Phase 4 study, sponsored by University of Florida.

NCT00308932 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00308932, a Phase 4 study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target

Study Summary

To determine the effect of age and device on delivery of HFA-Fluticasone Propionate (FP) in children of different ages. Hypothesis -- passive inhalation in younger children through a valved holding chamber/mask (VHC) will reduce the relative amount of FP delivered to airways.

Interventions

  • DRUG HFA FP MDI

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2003-02
Est. Completion 2004-04
Phase Phase 4
University of Florida

1,106 total trials

What the finished NCT00308932 record still lists

NCT00308932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which HFA FP MDI is the first listed.

NCT00308932 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00308932 about?

NCT00308932 is a clinical study titled "Effect of Age and Device on Delivery of Fluticasone". To determine the effect of age and device on delivery of HFA-Fluticasone Propionate (FP) in children of different ages. Hypothesis -- passive inhalation in younger children through a valved holding chamber/mask (VHC) will reduce the relative amount of FP delivered to airways.

What is the current status of trial NCT00308932?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2003-02. Estimated completion is 2004-04.

What interventions are being tested in trial NCT00308932?

The interventions under investigation include: HFA FP MDI (DRUG).

Who is sponsoring clinical trial NCT00308932?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00308932's enrollment target sits among peer trials

60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00308932, the US trial registry maintained by the National Library of Medicine. NCT00308932 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.